164 related articles for article (PubMed ID: 23581743)
1. Minocycline suppresses experimental autoimmune encephalomyelitis by increasing tissue inhibitors of metalloproteinases.
Niimi N; Kohyama K; Matsumoto Y
Neuropathology; 2013 Dec; 33(6):612-20. PubMed ID: 23581743
[TBL] [Abstract][Full Text] [Related]
2. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis.
Kieseier BC; Kiefer R; Clements JM; Miller K; Wells GM; Schweitzer T; Gearing AJ; Hartung HP
Brain; 1998 Jan; 121 ( Pt 1)():159-66. PubMed ID: 9549496
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states.
Pagenstecher A; Stalder AK; Kincaid CL; Shapiro SD; Campbell IL
Am J Pathol; 1998 Mar; 152(3):729-41. PubMed ID: 9502415
[TBL] [Abstract][Full Text] [Related]
5. Production of matrix metalloproteinases at the bone-implant interface in loose total hip replacements.
Yokohama Y; Matsumoto T; Hirakawa M; Kuroki Y; Fujimoto N; Imai K; Okada Y
Lab Invest; 1995 Dec; 73(6):899-911. PubMed ID: 8558853
[TBL] [Abstract][Full Text] [Related]
6. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells.
Ben-Hur T; Ben-Yosef Y; Mizrachi-Kol R; Ben-Menachem O; Miller A
J Neuroimmunol; 2006 Jun; 175(1-2):12-8. PubMed ID: 16580738
[TBL] [Abstract][Full Text] [Related]
7. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.
Sakaida I; Hironaka K; Kimura T; Terai S; Yamasaki T; Okita K
Life Sci; 2004 Mar; 74(18):2251-63. PubMed ID: 14987950
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and their inhibitors in human traumatic spinal cord injury.
Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
BMC Neurol; 2007 Jun; 7():17. PubMed ID: 17594482
[TBL] [Abstract][Full Text] [Related]
9. Upregulated expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in BALB/c mouse brain challenged with Japanese encephalitis virus.
Shukla V; Kumar Shakya A; Dhole TN; Misra UK
Neuroimmunomodulation; 2012; 19(4):241-54. PubMed ID: 22441541
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of MMP-8 and MMP-9 activity in the BALB/c mouse spinal cord correlates with the severity of experimental autoimmune encephalomyelitis.
Nygårdas PT; Hinkkanen AE
Clin Exp Immunol; 2002 May; 128(2):245-54. PubMed ID: 11985514
[TBL] [Abstract][Full Text] [Related]
11. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: a reverse transcription quantitative polymerase chain reaction study.
Ulrich R; Gerhauser I; Seeliger F; Baumgärtner W; Alldinger S
Dev Neurosci; 2005; 27(6):408-18. PubMed ID: 16280637
[TBL] [Abstract][Full Text] [Related]
13. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ
Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
15. Key metalloproteinases are expressed by specific cell types in experimental autoimmune encephalomyelitis.
Toft-Hansen H; Nuttall RK; Edwards DR; Owens T
J Immunol; 2004 Oct; 173(8):5209-18. PubMed ID: 15470066
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus.
Hu J; Zhang X; Nothnick WB; Spencer TE
Biol Reprod; 2004 Nov; 71(5):1598-604. PubMed ID: 15240428
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy.
Umehara F; Okada Y; Fujimoto N; Abe M; Izumo S; Osame M
J Neuropathol Exp Neurol; 1998 Sep; 57(9):839-49. PubMed ID: 9737547
[TBL] [Abstract][Full Text] [Related]
18. Activity, but not mRNA expression of gelatinases correlates with susceptibility to experimental autoimmune encephalomyelitis.
Petković F; Živanović J; Blaževski J; Timotijević G; Momčilović M; Stanojević Ž; Stamenković V; Milošević V; Mostarica Stojković M; Miljković Đ
Neuroscience; 2015 Apr; 292():1-12. PubMed ID: 25701126
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy.
Matsumoto Y; Park IK; Kohyama K
J Immunol; 2009 Oct; 183(7):4773-81. PubMed ID: 19734212
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
